Outcome | Intervention (n = 19) | Control (n = 20) | P value |
---|---|---|---|
Proportion of hours during the intervention period with RI value <20, median | 16 | 51 | 0.02 |
(1st, 3rd quartile; min–max) | (11, 45; 2–87) | (33, 72; 5–86) | |
RASS score at baseline, median | −4 | −4 | 0.76 |
(1st, 3rd quartile; min-max) | (−4, −3; −5 to −2) | (−4, −3; −5 to 0) | |
Proportion of hours with RASS score −4 or −5 during intervention period, median | 47 | 35 | 0.63 |
(1st, 3rd quartile; min-max) | (15, 65; 0–94) | (10, 72; 0–100) | |
Total propofol dose (mg) during intervention period, median | 1,090 | 2,380 | 0.14 |
(1st, 3rd quartile; min-max) | (375, 2,965; 100–7,290) | (1,510, 3,730; 60–8,630) | |
Total alfentanil dose (mg) during intervention period, median | 21.2 | 32.3 | 0.01 |
(1st, 3rd quartile; min-max) | (8.5, 27.9; 0.0–49.0) | (23.3, 49.8; 1.0–87.0) |